Fundz
Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Insitro Hires Chief Medical Officer To Advance Therapeutic Programs Toward the Clinic

PRIVATEJan 08, 2024over 2 years ago

Position

Chief Medical Officer

Company

Insitro

S. Michael Rothenberg
San FranciscoBiotechnologyHealth CareTherapeutics

Description

insitro, a machine learning-powered drug discovery and development company, today announced the appointment of S. Michael Rothenberg as chief medical officer. In this new role, which begins in February, Dr Rothenberg will lead all aspects of clinical development, including strategy on clinical trial design; oversee medical affairs, pharmacovigilance and regulatory affairs; and drive translational biology.

Company Information

Company

Insitro

Location

279 East Grand Avenue, Suite 200

San Francisco, California, United States

About

Insitro is an AI therapeutics company focused on drug discovery and development. The company utilizes machine learning techniques to enhance and expedite the process of pharmaceutical research. Insitro aims to transform the way drugs are discovered and developed, improving outcomes in healthcare. It has garnered respect in the biotech industry for its innovative approach.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Insitro's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.